Argos Therapeutics, Inc. to Present at Noble Financial Capital Markets' BIOX Life Sciences Exposition

DURHAM, N.C., Sept. 20, 2012 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis™ technology platform, announced today that its Chief Scientific Officer and Vice President, Research and Development, Charles Nicolette, PH.D., is presenting at BIOX: Noble Financial Capital Markets' Life Sciences Exposition to be held at the University of Connecticut, Stamford, Conn., on September 24-25, 2012.